| Mr Adnan Celjo, MD | |
|
1855 W Baseline Rd Ste 101, Mesa, AZ 85202 | |
| (480) 831-7566 | |
| Not Available |
| Full Name | Mr Adnan Celjo |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1855 W Baseline Rd Ste 101, Mesa, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144438243 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 43475 (Arizona) | Primary |
| Entity Name | District Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336472448 PECOS PAC ID: 7315086691 Enrollment ID: O20091125000583 |
News Archive
Female triathletes are at risk for pelvic floor disorders, decreased energy, menstrual irregularities and abnormal bone density, according to researchers at Loyola University Health System (LUHS).
Val J. Halamandaris, president of The National Association for Home Care and Hospice (NAHC), issued the following statement regarding the Senate Finance Committee Report on Home Health Services.
Roboticists are envisioning a future in which soft, animal-inspired robots could be safely deployed in difficult-to-access natural and man-made environments, such as in delicate surgical procedures in the human body, or in spaces too small and unpredictable to be conquered with rigid robots or too dangerous for humans to work with rigid robots in.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
› Verified 5 days ago
| Entity Name | Community Bridges Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558095315 PECOS PAC ID: 2062699721 Enrollment ID: O20110606000388 |
News Archive
Female triathletes are at risk for pelvic floor disorders, decreased energy, menstrual irregularities and abnormal bone density, according to researchers at Loyola University Health System (LUHS).
Val J. Halamandaris, president of The National Association for Home Care and Hospice (NAHC), issued the following statement regarding the Senate Finance Committee Report on Home Health Services.
Roboticists are envisioning a future in which soft, animal-inspired robots could be safely deployed in difficult-to-access natural and man-made environments, such as in delicate surgical procedures in the human body, or in spaces too small and unpredictable to be conquered with rigid robots or too dangerous for humans to work with rigid robots in.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
› Verified 5 days ago
| Entity Name | Livwell Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811527732 PECOS PAC ID: 1052738440 Enrollment ID: O20200831002515 |
News Archive
Female triathletes are at risk for pelvic floor disorders, decreased energy, menstrual irregularities and abnormal bone density, according to researchers at Loyola University Health System (LUHS).
Val J. Halamandaris, president of The National Association for Home Care and Hospice (NAHC), issued the following statement regarding the Senate Finance Committee Report on Home Health Services.
Roboticists are envisioning a future in which soft, animal-inspired robots could be safely deployed in difficult-to-access natural and man-made environments, such as in delicate surgical procedures in the human body, or in spaces too small and unpredictable to be conquered with rigid robots or too dangerous for humans to work with rigid robots in.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Adnan Celjo, MD 1855 W Baseline Rd Ste 101, Mesa, AZ 85202-9098 Ph: (480) 831-7566 | Mr Adnan Celjo, MD 1855 W Baseline Rd Ste 101, Mesa, AZ 85202 Ph: (480) 831-7566 |
News Archive
Female triathletes are at risk for pelvic floor disorders, decreased energy, menstrual irregularities and abnormal bone density, according to researchers at Loyola University Health System (LUHS).
Val J. Halamandaris, president of The National Association for Home Care and Hospice (NAHC), issued the following statement regarding the Senate Finance Committee Report on Home Health Services.
Roboticists are envisioning a future in which soft, animal-inspired robots could be safely deployed in difficult-to-access natural and man-made environments, such as in delicate surgical procedures in the human body, or in spaces too small and unpredictable to be conquered with rigid robots or too dangerous for humans to work with rigid robots in.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
› Verified 5 days ago
Amol Rohit Patel, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2028 | |
Dr. Kate Gillpatrick, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2000 | |
Nancy L Vander Veer, PSYD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 602-344-2002 Fax: 480-649-0783 | |
Dr. Yaniv Simon, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2026 Fax: 480-344-0219 | |
Dr. Samuel Hutchinson, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4135 S Power Rd, Mesa, AZ 85212 Phone: 480-397-2830 | |
Payam M Sadr, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2000 Fax: 480-649-0783 | |
Troy Michael Fulton, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3707 E Southern Ave, Mesa, AZ 85206 Phone: 480-509-7738 |